4/A: Charles River Labs Executive Shannon M. Parisotto Reports Changes in Beneficial Ownership

Sentiment:

SEC Filing


Shannon M. Parisotto, CEVP at Charles River Laboratories, reports transactions involving common stock, including acquisitions and disposals, following the achievement of performance goals.

Summary

  • This is an SEC Form 4/A filing indicating changes in beneficial ownership of Charles River Laboratories International, Inc. (CRL) stock by Shannon M. Parisotto, CEVP, Disc & Safety Assessment.
  • The report includes transactions from January 29, 2024, and amends a previous filing from January 31, 2024.
  • Parisotto acquired 2,070 shares of common stock following the achievement of performance goals set forth in performance share unit awards originally granted on May 28, 2021.
  • Parisotto also disposed of 535 shares of common stock at a price of $220.28.
  • Following these transactions, Parisotto directly owns 8,387 shares and indirectly owns 29,472 shares through Karpathos Investments LLC.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing stock transactions. The acquisition due to performance goals is mildly positive, while the disposal is mildly negative, balancing out overall.

Positives

  • The acquisition of shares indicates that performance goals were met, which could be viewed positively.

Negatives

  • The disposal of 535 shares could be interpreted negatively, although the amount is relatively small compared to the total holdings.

Risks

  • There are no specific risks mentioned in this document, as it primarily reports transactions in company stock.

Industry Context

This filing is a routine part of insider trading regulations and provides transparency into the transactions of company executives. It doesn't necessarily reflect broader industry trends but offers insight into individual executive actions.

Comparison to Industry Standards

  • Form 4 filings are standard practice for publicly traded companies and their executives.
  • The transactions are typical for executives receiving and selling shares as part of their compensation packages.
  • There are no specific projects or results to compare to industry standards in this document.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders by slightly altering the ownership structure.

Key Dates

DateDescription
May 28, 2021Date of original grant of performance share unit awards.
January 29, 2024Date of stock acquisition and disposal transactions.
January 31, 2024Date of original Form 4 filing.
March 22, 2024Date of amended Form 4/A filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.